New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery

Keyphrases

• Drug Delivery 100%
• Tuberculosis 100%
• Nanotechnology 100%
• Pharmacotherapy 66%
• Anti-tuberculosis Drugs 66%
• Commercially Available 33%
• Pediatric 33%
• Pediatric Patients 33%
• Therapeutic Agents 33%
• Infectious Diseases 33%
• Drug Interactions 33%
• Low Adherence 33%
• Nano-drug Delivery System 33%
• Drug Resistance 33%
• Treatment Course 33%
• High-risk Population 33%
• Antiretroviral Therapy 33%
• Resistant Strains 33%
• Therapeutic Failure 33%
• Low Compliance 33%
• Administration Schedule 33%
• Pharmaceutical Technology 33%
• Pill Burden 33%
• Novel Antibiotics 33%
• Infectious Reservoir 33%
• First-line Drugs 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacotherapy 100%
• Tuberculostatic Agent 100%
• Drug Delivery System 50%
• Pharmaceutical Technology 50%
• Infection 50%
• Antibiotic Agent 50%
• Zoonosis 50%
• Drug Interaction 50%
• Drug Resistance 50%